Colin Farrell says his personal life has inspired him to launch a new foundation aimed at helping people with intellectual disabilities. The actor, 48, recently launched the Colin Farrell Foundation, ...
Angelman syndrome is a rare condition that causes problems with growth and development. It’s caused by a genetic mutation (a change in your genes) that affects the nervous system. It’s named after ...
Add Yahoo as a preferred source to see more of our stories on Google. The rare neurogenetic disorder affects 1 in 15,000 people For the first time, Colin Farrell has opened up his home and talked ...
Angelman syndrome is a rare disease with a single known cause: one missing gene. The lack of that gene, normally inherited ...
Angelman syndrome triggers a false cellular stress alarm via asparagine synthetase, halting brain growth and protein synthesis.
Researchers from the University of Tokyo reveal how the presynaptic Ube3a E3 ligase, a causal factor in Angelman syndrome, eliminates neural chatter. The study helps find a better drug target for the ...
Researchers have identified a small molecule that could lead to a safe and effective treatment for the neurodevelopmental condition known as Angelman syndrome. Angelman syndrome is a rare genetic ...
Add Yahoo as a preferred source to see more of our stories on Google. The author, Christina Poletto, with her son Theo. (Courtesy Christina Poletto) It wasn't long after our son Theodore was born that ...
Dr. Joseph D'Orazio shares his experience working as a doctor and raising a child who has a rare disease, Angelman syndrome. D'Orazio explains how the experience has impacted his professional and ...
Researchers from the University of Tokyo reveal how the presynaptic Ube3a E3 ligase, a causal factor in Angelman syndrome, eliminates neural chat. The study helps find a better drug target for the ...
Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe neurodevelopmental disorder with no cure and limited treatments. Now, for the first time, scientists ...
Dear stakeholders, As you will be aware, the Department for Health & Social Care has asked NICE to carry out a Single Technology Appraisal of GID-TA12547 Apazunersen for treating Angelman syndrome.